DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
DeFronzo RA, Lee C, Kohler S.
Safety and tolerability of combinations of empagliflozin and linagliptin in patients with type 2 diabetes: pooled data from two randomized controlled trials.
Adv Ther 2018;
35: 1009-1022 . doi:10.1007/s12325-018-0724-y
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.